Kidswell Bio News

Kidswell Bio: Notice regarding the recording of non-operating income, non-operating expenses, special profit, and extraordinary loss

Nov 12 02:00 ET

Kidswell Bio: Announcement of the conclusion of a joint research agreement with Dokkyo Medical University and HOYA Technosurgical Co., Ltd. to develop new treatments for ischemic bone disease

Sep 30 02:00 ET

Kidswell Bio: Announcements of individual stocks regarding the recording of non-operating expenses.

Aug 14 02:30 ET

Kidswell Bio: Matters related to business plans and growth potential.

Jun 28 02:30 ET

Kidswell Bio: Regarding matters related to dominant shareholders.

Jun 28 02:30 ET

Kidswell Bio: Announcements of individual stocks regarding the conclusion of a business partnership agreement for joint development of new biosimilars with Kaiom Bioscience Co., Ltd.

Jun 18 03:00 ET

Kidswell Bio: Announcements of individual stocks regarding the conclusion of a business consignment contract to strengthen collaboration with the Biologics Research and Training Center (BCRET).

Jun 11 02:30 ET

Kidswell Bio: Independent Company Executives Declaration

Jun 3 23:00 ET

KIDSWELL BIO: Notice regarding the recording of non-operating expenses

May 14 04:00 ET

KIDSWELL BIO: Legal post-facto disclosure documents (newly established split) (S-Quatre Co., Ltd.)

Apr 25 02:30 ET

KIDSWELL BIO: Legal Advance Disclosure Documents (Newly Established Split) (S-Quatre Co., Ltd.)

Apr 25 02:30 ET

Kidswell Bio: Notice Concerning Borrowing of Funds

Mar 18 02:30 ET

Kidswell Bio: Notice regarding completion of production of master cell banks for baby tooth pulp stem cells (SHED) in accordance with US FDA standards

Mar 11 02:30 ET

Kidswell Bio: Notice regarding the election of candidates for directors and auditors

Mar 8 01:30 ET

Kidswell Bio: Notice regarding the recording of non-operating expenses

Feb 7 01:30 ET

Kidswell Bio: Supplementary explanatory materials on establishing a subsidiary

Jan 12 01:30 ET

Kidswell Bio: Notice regarding the establishment of a subsidiary in the cell therapy business (regenerative medicine) through a company split (simple new establishment split)

Jan 12 01:30 ET

Kidswell Bio: Notice regarding loan of funds

Dec 21, 2023 01:30 ET

Kidswell Bio: Notice regarding organizational changes and personnel changes

Dec 8, 2023 01:30 ET

Kidswell Bio: Notice regarding the listing of drug price standards and commencement of sales of pegfilgrastim biosimilar (GBS-010)

Nov 21, 2023 22:00 ET